Search Results - "Messa, Caterina"

Inflammatory Mechanisms of HCC Development by Refolo, Maria Grazia, Messa, Caterina, Guerra, Vito, Carr, Brian Irving, D'Alessandro, Rosalba

“…HCC (hepatocellular carcinoma) is the second leading cause of cancer deaths worldwide, with several etiologic causes, mostly inflammation-associated. Different…”
Get full text

Molecular mechanisms of synergistic action of Ramucirumab and Paclitaxel in Gastric Cancers cell lines by Refolo, Maria Grazia, Lotesoriere, Claudio, Lolli, Ivan Roberto, Messa, Caterina, D’Alessandro, Rosalba

“…Ramucirumab is approved both as monotherapy and in combination with Paclitaxel for advanced gastric cancer in patients with disease progression after…”
Get full text

Anti Proliferative and Pro Apoptotic Effects of Flavonoid Quercetin Are Mediated by CB1 Receptor in Human Colon Cancer Cell Lines by Refolo, Maria Grazia, D'Alessandro, Rosalba, Malerba, Natascia, Laezza, Chiara, Bifulco, Maurizio, Messa, Caterina, Caruso, Maria Gabriella, Notarnicola, Maria, Tutino, Valeria

“…Quercetin, the major constituent of flavonoid and widely present in fruits and vegetables, is an attractive compound for cancer prevention due to its…”
Get full text

Platelet extracts induce growth, migration and invasion in human hepatocellular carcinoma in vitro by Carr, Brian I, Cavallini, Aldo, D'Alessandro, Rosalba, Refolo, Maria Grazia, Lippolis, Catia, Mazzocca, Antonio, Messa, Caterina

“…Thrombocytopenia has been reported to be associated with small size HCCs, and thrombocytosis to be associated with large size HCCs. The aim was to examine the…”
Get full text

IGF-1R tyrosine kinase inhibitors and Vitamin K1 enhance the antitumor effects of Regorafenib in HCC cell lines by Refolo, Maria Grazia, D'Alessandro, Rosalba, Lippolis, Catia, Carella, Nicola, Cavallini, Aldo, Messa, Caterina, Carr, Brian Irving

“…The recent RESORCE trial showed that treatment with Regorafenib after Sorafenib failure provided a significant improvement in overall survival in HCC patients…”
Get full text

Nonalcoholic Fatty Liver Disease: Focus on New Biomarkers and Lifestyle Interventions by Notarnicola, Maria, Osella, Alberto Ruben, Caruso, Maria Gabriella, Pesole, Pasqua Letizia, Lippolis, Antonio, Tutino, Valeria, Bonfiglio, Caterina, De Nunzio, Valentina, Scavo, Maria Principia, Mirizzi, Antonella, Franco, Isabella, Lippolis, Tamara, D'Alessandro, Rosalba, Refolo, Maria Grazia, Messa, Caterina

“…Nonalcoholic fatty liver disease (NAFLD) is considered a hepatic manifestation of metabolic syndrome, characterized from pathological changes in lipid and…”
Get full text

Fluoro-Sorafenib (Regorafenib) effects on hepatoma cells: Growth inhibition, quiescence, and recovery by Carr, Brian I., Cavallini, Aldo, Lippolis, Catia, D'Alessandro, Rosalba, Messa, Caterina, Refolo, Maria G., Tafaro, Angela

“…To evaluate the growth‐inhibitory properties of the potent multi‐kinase antagonist Regorafenib (Fluoro‐Sorafenib), which was synthesized as a more potent…”
Get full text

Corrigendum: Variations in circulating levels of angiopoietin-2 over time are predictive of ramucirumab-paclitaxel therapy outcome in advanced gastric cancer: results of prospective study by D'Alessandro, Rosalba, Refolo, Maria Grazia, Schirizzi, Annalisa, De Leonardis, Giampiero, Donghia, Rossella, Guerra, Vito, Giannelli, Gianluigi, Lolli, Ivan Roberto, Laterza, Maria Maddalena, De Vita, Ferdinando, Messa, Caterina, Lotesoriere, Claudio

“…[This corrects the article DOI: 10.3389/fonc.2022.862116.]…”
Get full text

Variations in Circulating Levels of Angiopoietin-2 Over Time Are Predictive of Ramucirumab-Paclitaxel Therapy Outcome in Advanced Gastric Cancer: Results of Prospective Study by D'Alessandro, Rosalba, Refolo, Maria Grazia, Schirizzi, Annalisa, De Leonardis, Giampiero, Donghia, Rossella, Guerra, Vito, Giannelli, Gianluigi, Lolli, Ivan Roberto, Laterza, Maria Maddalena, De Vita, Ferdinando, Messa, Caterina, Lotesoriere, Claudio

“…The combination of paclitaxel and ramucirumab is the second-line therapy of choice in the treatment of advanced gastric cancer. To date, no biomarkers are…”
Get full text

The multiple combination of Paclitaxel, Ramucirumab and Elacridar reverses the paclitaxel-mediated resistance in gastric cancer cell lines by Schirizzi, Annalisa, Contino, Marialessandra, Carrieri, Livianna, Riganti, Chiara, De Leonardis, Giampiero, Scavo, Maria Principia, Perrone, Maria Grazia, Miciaccia, Morena, Kopecka, Joanna, Refolo, Maria Grazia, Lotesoriere, Claudio, Depalo, Nicoletta, Rizzi, Federica, Giannelli, Gianluigi, Messa, Caterina, D'Alessandro, Rosalba

“…Paclitaxel (PTX) interferes with microtubule architecture by binding to β-tubulin, thereby blocking progression at the G2/M phase and inducing apoptosis. This…”
Get full text

FZD10 Carried by Exosomes Sustains Cancer Cell Proliferation by Scavo, Maria Principia, Depalo, Nicoletta, Rizzi, Federica, Ingrosso, Chiara, Fanizza, Elisabetta, Chieti, Annarita, Messa, Caterina, Denora, Nunzio, Laquintana, Valentino, Striccoli, Marinella, Curri, Maria Lucia, Giannelli, Gianluigi

“…Extracellular vesicles (EVs) are involved in intercellular communication during carcinogenesis, and cancer cells are able to secrete EVs, in particular…”
Get full text

Antagonism of sorafenib and regorafenib actions by platelet factors in hepatocellular carcinoma cell lines by D'Alessandro, Rosalba, Refolo, Maria G, Lippolis, Catia, Giannuzzi, Grazia, Carella, Nicola, Messa, Caterina, Cavallini, Aldo, Carr, Brian I

“…Platelets are frequently altered in hepatocellular carcinoma (HCC) patients. Platelet lysates (hPL) can enhance HCC cell growth and decrease apoptosis. The…”
Get full text

Modulation of Regorafenib effects on HCC cell lines by epidermal growth factor by D’Alessandro, Rosalba, Refolo, Maria Grazia, Lippolis, Catia, Carella, Nicola, Messa, Caterina, Cavallini, Aldo, Carr, Brian Irving

“…Purpose Blood platelet numbers are correlated to growth and aggressiveness of several tumor types, including hepatocellular carcinoma (HCC). We previously…”
Get full text

VEGFA Status as a Predictive Marker of Therapy Outcome in Metastatic Gastric Cancer Patients Following Ramucirumab-Based Treatment by Schirizzi, Annalisa, Arshadi, Aram, Tolomeo, Doron, Schirosi, Laura, Valentini, Anna Maria, De Leonardis, Giampiero, Refolo, Maria Grazia, Donghia, Rossella, Storlazzi, Clelia Tiziana, Zito, Alfredo, Ricci, Angela Dalia, Vallarelli, Simona, Ostuni, Carmela, Bencivenga, Maria, De Manzoni, Giovanni, Messa, Caterina, Armentano, Raffaele, Giannelli, Gianluigi, Lotesoriere, Claudio, D'Alessandro, Rosalba

“…Metastatic gastric cancer (mGC) often has a poor prognosis and may benefit from a few targeted therapies. Ramucirumab-based anti-angiogenic therapy targeting…”
Get full text

Polyunsaturated fatty acids reduce fatty acid synthase and hydroxy-methyl-glutaryl CoA-reductase gene expression and promote apoptosis in HepG2 cell line by Notarnicola, Maria, Messa, Caterina, Refolo, Maria G, Tutino, Valeria, Miccolis, Angelica, Caruso, Maria G

“…n-3 and n-6 polyunsaturated fatty acids (PUFAs) are the two major classes of PUFAs encountered in the diet, and both classes of fatty acids are required for…”
Get full text

Synergic effect of eicosapentaenoic acid and lovastatin on gene expression of HMGCoA reductase and LDL receptor in cultured HepG2 cells by Notarnicola, Maria, Messa, Caterina, Refolo, Maria G, Tutino, Valeria, Miccolis, Angelica, Caruso, Maria G

“…PUFAs are potent inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, an enzyme catalyzing the conversion of HMGCoA to mevalonate, the rate…”
Get full text

Modulation of Doxorubicin mediated growth inhibition of hepatocellular carcinoma cells by platelet lysates by Refolo, Maria Grazia, D'Alessandro, Rosalba, Lippolis, Catia, Messa, Caterina, Carella, Nicola, Cavallini, Aldo, Carr, Brian I

“…Platelet extracts can stimulate cell growth and contribute to tumor biology. It was recently shown that they stimulate the growth of hepatocellular carcinoma…”
Get more information

Up-regulation of 3-Hydroxy-3-methylglutaryl Coenzyme A Reductase Activity in Left-sided Human Colon Cancer by NOTARNICOLA, Maria, MESSA, Caterina, PRICCI, Maria, GUERRA, Vito, ALTOMARE, Donato Francesco, MONTEMURRO, Severino, CARUSO, Maria Gabriella

“…Background. We evaluated the HMGCoA reductase activity and LDL receptor levels in human colon cancer as well as the effects of simvastatin on in vitro cell…”
Get full text

N6‐isopentenyladenosine inhibits cell proliferation and induces apoptosis in a human colon cancer cell line DLD1 by Laezza, Chiara, Caruso, Maria Gabriella, Gentile, Teresa, Notarnicola, Maria, Malfitano, Anna Maria, Di Matola, Tiziana, Messa, Caterina, Gazzerro, Patrizia, Bifulco, Maurizio

“…N6‐isopentenyladenosine (i6A) is a modified nucleoside with a pentaatomic isopentenyl derived from mevalonate that induces inhibition of tumor cell…”
Get full text

Effect of genistein on cholesterol metabolism-related genes in a colon cancer cell line by Notarnicola, Maria, Messa, Caterina, Orlando, Antonella, D'Attoma, Benedetta, Tutino, Valeria, Rivizzigno, Rosemary, Caruso, Maria Gabriella

“…The major soy-derived isoflavones such as genistein has been demonstrated to possess anticarcinogenic activity in animal model systems. The present study was…”
Get full text